CWBHF - Charlotte's Web Holdings, Inc.
OTC
->
Healthcare
->
Drug Manufacturers—Specialty & Generic
Louisville,
United States
Type: Equity
CWBHF price evolution
CWBHF
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $32.53 | $38.51 | $47.82 | $51.02 |
| Short term investments | $1.17 | |||
| Net receivables | $1.87 | $1.72 | $2.33 | $2.49 |
| Inventory | $18.67 | $22.49 | $21.54 | $22.63 |
| Total current assets | $56.93 | $68.26 | $78.17 | $83.74 |
| Long term investments | $11.89 | $11 | $11 | $11.1 |
| Property, plant & equipment | $41.94 | $42.46 | $42.11 | $43.12 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $129.79 | $141.78 | $152.55 | $163.87 |
| Current liabilities | ||||
| Accounts payable | $4.35 | $3.99 | $2.86 | $3.58 |
| Deferred revenue | ||||
| Short long term debt | $2.38 | $2.34 | $2.25 | $2.25 |
| Total current liabilities | $18.47 | $19.63 | $23.65 | $24.78 |
| Long term debt | $43.46 | $42.74 | $42.53 | $40.39 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $93.97 | $95.11 | $96.99 | $100.13 |
| Shareholders' equity | ||||
| Retained earnings | -$292.41 | -$281.36 | -$271.72 | -$263.14 |
| Other shareholder equity | ||||
| Total shareholder equity | $35.83 | $46.67 | $55.56 | $63.74 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $47.82 | $66.96 | $19.49 | $52.8 |
| Short term investments | $1.17 | $2.31 | $0.93 | $2.74 |
| Net receivables | $2.33 | $2.42 | $17.09 | $20.47 |
| Inventory | $21.54 | $26.95 | $52.08 | $63.16 |
| Total current assets | $78.17 | $103.76 | $95.81 | $143.79 |
| Long term investments | $11 | |||
| Property, plant & equipment | $42.11 | $45.85 | $56.76 | $60.4 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $152.55 | $187.64 | $171.51 | $310.79 |
| Current liabilities | ||||
| Accounts payable | $2.86 | $4.02 | $5.05 | $4.89 |
| Deferred revenue | ||||
| Short long term debt | $2.25 | $2.31 | $2.1 | |
| Total current liabilities | $23.65 | $21.43 | $20.17 | $28.87 |
| Long term debt | $42.53 | $37.42 | ||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $96.99 | $110.14 | $41.07 | $56.55 |
| Shareholders' equity | ||||
| Retained earnings | -$271.72 | -$247.93 | -$188.61 | -$50.89 |
| Other shareholder equity | ||||
| Total shareholder equity | $55.56 | $77.5 | $130.45 | $254.24 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $12.29 | $12.12 | $15.84 | $14.29 |
| Cost of revenue | $9.71 | $5.21 | $7.04 | $6.36 |
| Gross Profit | $2.58 | $6.91 | $8.8 | $7.93 |
| Operating activities | ||||
| Research & development | $0.65 | $0.75 | $0.77 | $0.73 |
| Selling, general & administrative | $12.44 | $12.89 | $23.9 | $16.31 |
| Total operating expenses | $24.43 | $20.49 | $26.25 | |
| Operating income | -$12.14 | -$8.37 | -$9.8 | -$11.96 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.05 | $0.02 | $0.53 | |
| Interest expense | ||||
| Net income | ||||
| Net income | -$11.06 | -$9.63 | -$8.58 | -$15.14 |
| Income (for common shares) | -$11.06 | -$9.63 | -$15.14 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $63.16 | $74.14 | $96.09 | $95.23 |
| Cost of revenue | $27.59 | $54.73 | $48.56 | $42.94 |
| Gross Profit | $35.57 | $19.41 | $47.53 | $52.29 |
| Operating activities | ||||
| Research & development | $2.96 | $3.44 | $5.5 | $5.95 |
| Selling, general & administrative | $69.92 | $62.22 | $83.04 | $88.11 |
| Total operating expenses | $103.22 | $124.79 | $145.15 | $142.67 |
| Operating income | -$50.65 | -$49.06 | -$47.45 | |
| Income from continuing operations | ||||
| EBIT | -$49.06 | -$47.45 | ||
| Income tax expense | $0.53 | $0.09 | $0.14 | -$8.01 |
| Interest expense | ||||
| Net income | ||||
| Net income | -$23.8 | -$59.31 | -$137.72 | -$30.68 |
| Income (for common shares) | -$59.31 | -$137.72 | -$30.68 | |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | -$11.06 | -$9.63 | -$8.58 | -$15.14 |
| Operating activities | ||||
| Depreciation | $1.46 | $1.52 | $3.65 | $3.74 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$4.7 | -$7.18 | -$2.54 | -$7.84 |
| Investing activities | ||||
| Capital expenditures | -$1.26 | -$2.06 | -$0.68 | -$2.83 |
| Investments | ||||
| Total cash flows from investing | -$1.26 | -$2.03 | -$0.61 | -$2.74 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$0.02 | -$0.1 | -$0.05 | -$0.13 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$5.98 | -$9.31 | -$3.2 | -$10.71 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Net income | -$23.8 | -$59.31 | -$137.72 | -$30.68 |
| Operating activities | ||||
| Depreciation | $7.74 | $11.02 | $6.85 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$15.39 | -$5.32 | -$29.56 | -$52.03 |
| Investing activities | ||||
| Capital expenditures | -$3.69 | -$0.27 | -$4.92 | -$28.26 |
| Investments | ||||
| Total cash flows from investing | -$3.51 | $0.4 | -$11.79 | -$19.16 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $8.29 | |||
| Net borrowings | $52.76 | |||
| Total cash flows from financing | -$0.25 | $52.39 | $8.04 | $55.44 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$19.14 | $47.47 | -$33.31 | -$15.75 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $54.54M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$44.41M |
| Revenue Q/Q | -23.24% |
| Revenue Y/Y | -20.88% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | -30.21% |
| ROE | -88.03% |
| Debt/Equity | 1.75 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 3.08 |
| Quick ratio | 2.07 |